- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02087514
Duration of Red Blood Cell Storage Prior to Transfusion
Duration of Red Blood Cell Storage Prior to Transfusion and Non-Transferrin-Bound Iron
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Recent studies suggest that older stored blood is associated with worse outcomes in certain hospitalized patients. Red cells may be stored in a refrigerator prior to transfusion for up to 42 days by current FDA standards. Refrigerator storage of red cells is associated with a storage lesion and the survival of transfused red cells decreases with increasing storage time, thus older blood is associated with an increased delivery of hemoglobin-iron to certain parts of the body. The investigators have preliminary data in mice and humans suggesting that delivery of a significant iron load from aged red cells leads to the production of a potentially toxic form of circulating iron called non-transferrin-bound iron.
In this prospective study of healthy volunteers, each subject will be randomized to receive transfusion of one RBC unit after 1, 2, 3, 4, 5, or 6 weeks of storage. The primary outcome will be the 24 hr area under the curve (AUC) of the serum non-transferrin bound iron concentration calculated from samples collected at 0, 2, 4, 6, 8, 10, 12, 14 and 24 hours after transfusion.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18-65 years old
- Body weight >110 lbs
- Hemoglobin >12.5 g/dL
Exclusion Criteria:
- Ineligible for donation based on the New York Blood Center blood donor questionnaire
- Systolic blood pressure >180 or <90 mm Hg, diastolic blood pressure >100 or <50 mm Hg
- Heart rate <50 or >100
- Temperature >99.5 F prior to donation
- Temperature >100.4 F or subjective feeling of illness prior to transfusion (this is to avoid having a concurrent illness affect post-transfusion measurements);
- Positive results on standard blood donor infectious disease testing
- Positive urine pregnancy test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Transfusion of PRBC stored for 1 week
Subjects will receive blood transfusion with packed red blood cells stored for 1 week.
|
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion. A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank. The number of weeks in storage are as follows:
Other Names:
|
Experimental: Transfusion of PRBC stored for 2 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 2 weeks.
|
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion. A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank. The number of weeks in storage are as follows:
Other Names:
|
Experimental: Transfusion of PRBC stored for 3 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 3 weeks.
|
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion. A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank. The number of weeks in storage are as follows:
Other Names:
|
Experimental: Transfusion of PRBC stored for 4 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 4 weeks.
|
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion. A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank. The number of weeks in storage are as follows:
Other Names:
|
Experimental: Transfusion of PRBC stored for 5 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 5 weeks.
|
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion. A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank. The number of weeks in storage are as follows:
Other Names:
|
Experimental: Transfusion of PRBC stored for 6 weeks
Subjects will receive blood transfusion with packed red blood cells stored for 6 weeks.
|
A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.
Other Names:
Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion. A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank. The number of weeks in storage are as follows:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Non-transferrin-bound Iron Level (AUC)
Time Frame: 0, 2, 4, 6, 8, 10, 12, 14 and 24 after transfusion
|
Area under the curve of change of Non-transferrin-bound iron from immediately after transfusion to end of observation (i.e., from 0-hr after transfusion to 24-hr after transfusion).
|
0, 2, 4, 6, 8, 10, 12, 14 and 24 after transfusion
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Steven L Spitalnik, MD, Columbia University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AAAI0835
- R01HL115557 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron, Blood Level Abnormal
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedIron, Abnormal Blood LevelUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedIron, Abnormal Blood Level | Other Abnormal Blood ChemistryUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedIron-deficiency | Anemia | Iron Deficiency Anemia | Iron Deficiency Anemia Treatment | Blood Loss Anemia | Erythropoiesis AbnormalItaly
-
Hamad Medical CorporationCompletedBronchiolitis | Magnesium, Abnormal Blood LevelQatar
-
University of CalgaryNot yet recruitingIron Deficiency Anemia | Abnormal Uterine Bleeding
-
Baylor College of MedicineCompletedIron Deficiency Anemia | Heavy Menstrual Bleeding | Abnormal Uterine BleedingUnited States
-
University of British ColumbiaCompleted
-
University of British ColumbiaCompletedHeart Rate | Blood Oxygen Saturation LevelCanada
-
InQpharm GroupCompletedBlood Pressure | Low Density Lipoprotein Cholesterol LevelGermany
-
Assaf-Harofeh Medical CenterCompletedAspirin Blood Level | Proton Pump Inhiditor TreatmentIsrael
Clinical Trials on Blood Transfusion
-
Hamad Medical CorporationSidra Medical and Research Center; World Anti-Doping Agency; Anti-Doping Lab... and other collaboratorsUnknownBlood Disease | Blood Transfusion, Autologous | Blood Doping | Blood Transfusion, HomologousQatar
-
Hospital PitangueirasUnknown
-
Emory UniversityWithdrawnHematopoietic and Lymphoid Cell Neoplasm | Leukemia | Anemia | Myelodysplastic Syndrome | Aplastic Anemia | Bone Marrow FailureUnited States
-
Haukeland University HospitalDentsply Sirona Implants and ConsumablesCompleted
-
Mahidol UniversityWolf Schleinzer Stiftung zur Wissenschafts- und Bildungsförderung, GermanyCompletedSurgery | Immune Defect | Incompatible Blood TransfusionThailand
-
Oregon Health and Science UniversityNot yet recruitingTraumatic Brain Injury
-
Assistance Publique - Hôpitaux de ParisCompletedMyocardial Infarction | Anemia | Blood TransfusionSpain, France
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Primary Myelofibrosis | Thrombocytopenia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Venous Thromboembolism | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaboratorsRecruitingThe Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy VolunteersFrance
-
Direction Centrale du Service de Santé des ArméesFloralis; TIMC-IMAGRecruitingTrauma | Coagulopathy | Acute HemorrhageFrance